Salient Trust Company Lta Decreased By $428,120 Its Abbvie (ABBV) Stake; B2Gold Corp. (TSE:BTO) Covered By 8 Bulls

January 19, 2018 - By Adrian Erickson

Among 8 analysts covering B2gold Corp. (TSE:BTO), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. B2gold Corp. had 30 analyst reports since August 18, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Friday, November 10 by Scotia Capital. The stock has “Outperform” rating by BMO Capital Markets on Tuesday, December 5. Dundee Securities reinitiated the stock with “Buy” rating in Thursday, February 4 report. The firm has “Outperform” rating given on Friday, April 21 by Scotia Capital. The stock of B2Gold Corp. (TSE:BTO) earned “Outperform” rating by RBC Capital Markets on Monday, August 24. BMO Capital Markets maintained the stock with “” rating in Monday, April 3 report. JP Morgan initiated the shares of BTO in report on Thursday, February 4 with “Overweight” rating. The firm earned “Outperform” rating on Friday, June 16 by BMO Capital Markets. The firm earned “Outperform” rating on Friday, October 14 by Scotia Capital. The firm earned “Outperform” rating on Wednesday, October 19 by B2Gold Corp.. See B2Gold Corp. (TSE:BTO) latest ratings:

05/12/2017 Broker: BMO Capital Markets Rating: Outperform New Target: $5.00 Maintain
10/11/2017 Broker: Scotia Capital Rating: Outperform New Target: $4.75 Maintain
29/09/2017 Broker: Canaccord Genuity Rating: Old Target: $5.00 New Target: $5.50 Target Up

Salient Trust Company Lta decreased Abbvie Inc (ABBV) stake by 12.04% reported in 2017Q3 SEC filing. Salient Trust Company Lta sold 4,865 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Salient Trust Company Lta holds 35,556 shares with $3.16 million value, down from 40,421 last quarter. Abbvie Inc now has $166.18 billion valuation. The stock increased 0.28% or $0.285 during the last trading session, reaching $104.095. About 2.63 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 19, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.15, from 1 in 2017Q2. It turned negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Security Commercial Bank Of So Dak invested 1.43% in AbbVie Inc. (NYSE:ABBV). Washington-based Cornerstone Advsrs has invested 0.17% in AbbVie Inc. (NYSE:ABBV). Bar Harbor Tru Services accumulated 2,252 shares. Moreover, Df Dent Communications Inc has 0.02% invested in AbbVie Inc. (NYSE:ABBV) for 7,682 shares. Seaward Mgmt Partnership owns 169,578 shares for 0.74% of their portfolio. Connors Investor Services Incorporated reported 77,336 shares. Ronna Sue Cohen has invested 1.75% of its portfolio in AbbVie Inc. (NYSE:ABBV). Camelot Portfolios Ltd invested in 0.23% or 5,298 shares. Linscomb & Williams invested in 63,035 shares. Neuberger Berman Grp Limited Liability holds 612,588 shares. Orca Invest Mgmt Ltd Co reported 7,309 shares. Chatham Grp has invested 2.01% in AbbVie Inc. (NYSE:ABBV). Asset Mngmt Of Georgia Ga Adv stated it has 0.75% of its portfolio in AbbVie Inc. (NYSE:ABBV). 3,560 were accumulated by Argent Capital Management Limited Co. First Dallas Securities reported 27,190 shares.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 71 analyst reports since July 21, 2015 according to SRatingsIntel. On Wednesday, April 6 the stock rating was initiated by Societe Generale with “Sell”. The firm has “Buy” rating given on Friday, October 23 by UBS. The stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given on Monday, November 20 by Cowen & Co. The stock of AbbVie Inc. (NYSE:ABBV) has “Neutral” rating given on Monday, November 28 by Citigroup. The firm has “Hold” rating given on Wednesday, June 7 by BMO Capital Markets. JP Morgan downgraded the shares of ABBV in report on Thursday, September 8 to “Neutral” rating. The company was maintained on Friday, July 28 by Cowen & Co. The stock of AbbVie Inc. (NYSE:ABBV) has “Overweight” rating given on Monday, November 2 by Morgan Stanley. The rating was maintained by SunTrust on Monday, October 16 with “Buy”. Goldman Sachs downgraded the stock to “Buy” rating in Monday, March 7 report.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 EPS, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28B for 18.20 P/E if the $1.43 EPS becomes a reality. After $1.41 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

Since July 31, 2017, it had 0 buys, and 8 selling transactions for $45.57 million activity. Michael Robert A. had sold 6,699 shares worth $589,512 on Thursday, September 28. $1.66 million worth of stock was sold by Gosebruch Henry O on Monday, October 30. The insider RICHMOND TIMOTHY J. sold 87,040 shares worth $8.57 million. Shares for $705,655 were sold by SALEKI-GERHARDT AZITA. The insider GONZALEZ RICHARD A sold 193,131 shares worth $13.71M. Schumacher Laura J had sold 145,510 shares worth $14.07M on Thursday, December 14.

B2Gold Corp, together with its subsidiaries, engages in the exploration and development of mineral properties in Nicaragua, the Philippines, Namibia, Mali, Colombia, Burkina Faso, and Finland. The company has market cap of $3.71 billion. It primarily explores for gold, silver, and copper deposits. It has a 111.47 P/E ratio. The companyÂ’s production properties include the La Libertad mine with an exploitation concession covering an area of 10,950 hectares and the El Limon mine covering an area of 12,000 hectares located in Nicaragua; the Masbate mine covering an area of approximately 15,209 hectares located in the Philippines; and the Otjikoto mine covering an area of 6,933.99 hectares located in Namibia.

Investors sentiment increased to 1.56 in 2017 Q3. Its up 0.35, from 1.21 in 2017Q2. It improved, as 6 investors sold B2Gold Corp. shares while 10 reduced holdings. 9 funds opened positions while 16 raised stakes. 3.60 million shares or 3.66% more from 3.47 million shares in 2017Q2 were reported. North Star Invest Corp reported 47 shares. 16,750 are held by Community Bancshares Of Raymore. Cohen And Steers Incorporated invested in 16,526 shares or 0% of the stock. Bancshares Of Montreal Can stated it has 11,871 shares or 0% of all its holdings. Oakworth Capital invested in 700 shares or 0.01% of the stock. The Florida-based Raymond James & Associates has invested 0.01% in B2Gold Corp. (TSE:BTO). Moreover, Commonwealth Equity Ser Inc has 0% invested in B2Gold Corp. (TSE:BTO) for 17,926 shares. Patten Grp Inc, Tennessee-based fund reported 4,631 shares. Bancorporation Of America Corporation De reported 0% in B2Gold Corp. (TSE:BTO). Moreover, Citigroup has 0% invested in B2Gold Corp. (TSE:BTO). Winslow Evans Crocker owns 11,400 shares for 0.14% of their portfolio. North Star Asset Management reported 164,127 shares. Patten Patten Tn has 303,590 shares for 1.19% of their portfolio. Lpl Financial Lc holds 0% or 12,069 shares. Texas-based Next Finance Group has invested 0.01% in B2Gold Corp. (TSE:BTO).

The stock increased 0.26% or $0.01 during the last trading session, reaching $3.79. About 2.14 million shares traded. B2Gold Corp. (TSE:BTO) has 0.00% since January 19, 2017 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts